“…In Europe in 2004, and in the USA in 2006, PentaBDE and OctaBDE mixtures were phased out from production due to concern over observed toxic effects (EPA U, 2006;EU, 2003). This led to temporarily increases in the production of DecaBDE mixtures, resulting in elevated concentrations of BDE 209 (the major congener in DecaBDE mixture) and decreasing concentrations of BDE 154 and BDE 183 (representative of PentaBDE and OctaBDE mixtures) in environmental samples (Law et al, 2014;Venkatesan and Halden, 2014). Following the restriction of the use of PBDE mixtures, there was also an increase in the production and usage of HBCD (Al-Odaini et al, 2015;Law et al, 2006).…”